Evidence from patients with psoriasis demonstrates upregulation of the PI3K/Akt pathway in peripheral blood cells and reduced levels of the Akt downstream mediator, FOXO, in psoriatic lesions (Ochaion et al., 2009; Liu et al., 2011). This evidence concerns the gene AKT1 and psoriasis.